Dr William Dall'Acqua | VP, R&D
MedImmune

Dr William Dall'Acqua, VP, R&D, MedImmune

William F. Dall'Acqua, Ph.D. is VP, Research and Development at MedImmune, a biopharmaceutical company headquartered in Gaithersburg, Maryland.  Dr. Dall'Acqua has been studying protein structure, function and engineering for over twenty years and has co-authored over sixty papers and one book chapter in the field.  He has also been named inventor on more than eighty patent applications and on eighteen issued patents.  He has B.S. and Masters Degrees in Biochemistry from University of Paris, and a Ph.D. in Immunology from University of Paris in conjunction with University of Maryland.  He also spent two and a half years as a post-doctoral fellow at Genentech in the Molecular Oncology Department before joining MedImmune.  At MedImmune, Dr. Dall'Acqua supervises a group of over thirty scientists in the Department of Antibody Discovery and Protein Engineering, working on discovery of new therapeutic antibody drugs and establishing novel technology platforms

Appearances:



European Antibody Congress 2018, Day 2 @ 11:25

Insights into the molecular basis of a bispecific antibody’s target and tumor-targeting selectivity

last published: 15/Aug/18 09:25 GMT
last published: 15/Aug/18 09:25 GMT
last published: 15/Aug/18 09:25 GMT
last published: 15/Aug/18 09:25 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.


Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates